These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1841753)

  • 1. Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer.
    Heston WD
    Cancer Surv; 1991; 11():217-38. PubMed ID: 1841753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
    Heston WD; Kadmon D; Covey DF; Fair WR
    Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
    Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-independent polyamine metabolism of squamous cell carcinoma of the prostate.
    Shukla GS; Singhal RL
    Cell Biochem Funct; 1985 Jul; 3(3):185-92. PubMed ID: 3836020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line.
    Heston WD; Yang CR; Pliner L; Russo P; Covey DF
    Cancer Res; 1987 Jul; 47(14):3627-31. PubMed ID: 3109728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer.
    Dunzendorfer U; Releyea N; Whitmore WF; Fogh J; Balis ME
    Arzneimittelforschung; 1984; 34(1):36-9. PubMed ID: 6422951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
    Gawel-Thompson KJ; Greene RM
    J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.
    Li W; Liu X; Wang W; Sun H; Hu Y; Lei H; Liu G; Gao Y
    Prostate; 2008 Sep; 68(12):1354-61. PubMed ID: 18548481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
    Dunzendorfer U; Relyea NM; Kleinert E; Balis ME; Whitmore WF
    Oncology; 1983; 40(1):57-62. PubMed ID: 6401860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.
    Pegg AE
    Cancer Res; 1988 Feb; 48(4):759-74. PubMed ID: 3123052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.
    Porter CW; McManis J; Casero RA; Bergeron RJ
    Cancer Res; 1987 Jun; 47(11):2821-5. PubMed ID: 3567905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polyamines, polyamine antimetabolites and urogenital tumors. State of research and clinical results].
    Dunzendorfer U
    Urol Int; 1985; 40(5):241-50. PubMed ID: 3934827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration.
    Kallio A; Seppänen P; Alhonen-Hongisto L; Jänne J
    Cancer Res; 1983 Jan; 43(1):324-7. PubMed ID: 6401167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
    Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
    J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.
    Meyskens FL; Simoneau AR; Gerner EW
    Recent Results Cancer Res; 2014; 202():115-20. PubMed ID: 24531785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells.
    Käpyaho K; Sinervirta R; Jänne J
    Cancer Res; 1985 Apr; 45(4):1444-8. PubMed ID: 3919940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Na(+)-dependent and the Na(+)-independent polyamine transporters in renal epithelial cells (LLC-PK1).
    Parys JB; De Smedt H; Van Den Bosch L; Geuns J; Borghgraef R
    J Cell Physiol; 1990 Sep; 144(3):365-75. PubMed ID: 2118145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible implications of arginase and diamine oxidase in prostatic carcinoma.
    Keskinege A; Elgün S; Yilmaz E
    Cancer Detect Prev; 2001; 25(1):76-9. PubMed ID: 11270424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal keratinocytes actively maintain their intracellular polyamine levels.
    Roseeuw DI; Marcelo CL; Rhodes LM; Voorhees JJ
    Cell Tissue Kinet; 1983 Sep; 16(5):493-504. PubMed ID: 6192925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in gene expression in response to polyamine depletion indicates selective stabilization of mRNAs.
    Veress I; Haghighi S; Pulkka A; Pajunen A
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):185-91. PubMed ID: 10657256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.